Search

shutterstock_2261453831(1) (1)

Announcements

Announcements

HOMEWhat’s NewAnnouncements

2022.Nov.24

The Company’s BOD resolved to forfeit part of subscription rights of Obigen’s cash capital increase and distribute the rights to its shareholders

2022.Nov.23

The Company correct the information on monetary loans extended to others filed on September and October 2022

2022.Nov.14

Announcement on behalf of AP Biosciences that application for Phase I human clinical trial of Bispecific Antibody, AP203, has been granted by TFDA

2022.Nov.09

Announcement on behalf of APBio’s resolution to lift non-competition restrictions for directors at 2022 extraordinary Shareholders' Meeting

2022.Nov.09

Announcement on behalf of AP Biosciences. regarding its by-election of director and supervisor at 2022 first extraordinary General Shareholders' Meeting

2022.Nov.09

Announcement on behalf of AP Biosciences’ important resolutions of 2022 first extraordinary General Shareholders' Meeting

2022.Nov.04

Announcement of the Consolidated Financial Statements for the third quarter of 2022 were approved by the Board of Directors

2022.Oct.25

The Chairman decided the record date of 2022 first issuance of RSU according to the resolution Of BOD

2022.Oct.18

Announcement on behalf of AP Biosciences that the BOD resolved to convene 2022 first extraordinary General Shareholders' Meeting

2022.Oct.13

OBI-822 “Cancer Immunotherapy by Immune Activation or Immune Modulation via Globo Series Antigens“ was granted by USPTO

News

Latest News

Events

Latest events